Abstract:Background C-reactive protein (CRP) is a candidate biomarker for major depressive disorder (MDD), but it is unclear how peripheral CRP levels relate to the heterogeneous clinical phenotypes of the disorder. Aim To explore CRP in MDD and its phenotypic associations. Method We recruited 102 treatment-resistant patients with MDD currently experiencing depression, 48 treatment-responsive patients with MDD not currently experiencing depression, 48 patients with depression who were not receiving medication and 54 healthy volunteers. High-sensitivity CRP in peripheral venous blood, body mass index (BMI) and questionnaire assessments of depression, anxiety and childhood trauma were measured. Group differences in CRP were estimated, and partial least squares (PLS) analysis explored the relationships between CRP and specific clinical phenotypes. Results Compared with healthy volunteers, BMI-corrected CRP was significantly elevated in the treatment-resistant group ( P = 0.007; Cohen's d = 0.47); but not significantly so in the treatment-responsive ( d = 0.29) and untreated ( d = 0.18) groups. PLS yielded an optimal two-factor solution that accounted for 34.7% of variation in clinical measures and for 36.0% of variation in CRP. Clinical phenotypes most strongly associated with CRP and heavily weighted on the first PLS component were vegetative depressive symptoms, BMI, state anxiety and feeling unloved as a child or wishing for a different childhood. Conclusions CRP was elevated in patients with MDD, and more so in treatment-resistant patients. Other phenotypes associated with elevated CRP included childhood adversity and specific depressive and anxious symptoms. We suggest that patients with MDD stratified for proinflammatory biomarkers, like CRP, have a distinctive clinical profile that might be responsive to second-line treatment with anti-inflammatory drugs. Declaration of interest S.R.C. consults for Cambridge Cognition and Shire; and his input in this project was funded by a Wellcome Trust Clinical Fellowship (110049/Z/15/Z). E.T.B. is employed half time by the University of Cambridge and half time by GlaxoSmithKline; he holds stock in GlaxoSmithKline. In the past 3 years, P.J.C. has served on an advisory board for Lundbeck. N.A.H. consults for GlaxoSmithKline. P.d.B., D.N.C.J. and W.C.D. are employees of Janssen Research & Development, LLC., of Johnson & Johnson, and hold stock in Johnson & Johnson. The other authors report no financial disclosures or potential conflicts of interest.

The Association of Depressive Symptoms With Plasma C-Reactive Protein in Patients With Major Depressive Disorder Under Treatment

Association between Depression and C-Reactive Protein

Treatment-resistant depression and peripheral C-reactive protein

Association of heart rate variability and C-reactive protein in patients with depression

Network analysis of depressive symptoms and C-reactive protein levels in major depressive disorder

Correlation of Serum High-Sensitivity C-Reactive Protein, Homocysteine, and Macrophage Migration Inhibitory Factor Levels With Symptom Severity and Cognitive Function in Patients With Schizophrenia

Associations between C-reactive protein and individual symptoms of depression in a lower-middle income country

Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

C-reactive protein (CRP) level in depressed patients with suicidal behavior: A systematic review and meta-analysis

Elevated C-Reactive Protein and Erythrocyte Sedimentation Rate Correlates with Depression in Psoriasis: A Chinese Cross-Sectional Study

Study of decreased serum levels of C1q/TNF-related protein 4 (CTRP4) in major depressive disorder

Association between C-reactive protein and depression: modulated by gender and mediated by body weight.

Depressive Symptoms and C-Reactive Protein Are Not Associated in a Population-Based Sample of Adolescents

Abstract TP24: C-Reactive Protein, and Homocysteine as a Predictors of Post Stroke Depression Among Stroke Patients: A Meta-Analysis and Meta Regression

Association between C-reactive protein and mood disorder in a representative sample of the Canadian population: analysis of CHMS data 2013–2014

The association between cortisol:C-reactive protein ratio and depressive fatigue is a function of CRP rather than cortisol

The combined effects of depression or anxiety with high-sensitivity C-reactive protein in predicting the prognosis of coronary heart disease patients

The Relationship Between Depression and C Reactive Protein in Patients with Chronic Ischemic Heart Failure

An inflamed subtype of difficult-to-treat depression

Can high-sensitivity C-reactive protein be a routine trans-diagnostic biomarker for thoughts of death and suicidal attempts?

Disturbances in Acute Phase Plasma Proteins During Melancholia: Additional Evidence for the Presence of an Inflammatory Process During That Illness